TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
TWD 9.51
(2.26%)
TWD 9.51
(2.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 123.13 Million TWD | 239.87% |
| 2022 | 36.23 Million TWD | -97.2% |
| 2021 | 1.29 Billion TWD | 5426.95% |
| 2020 | 23.42 Million TWD | 15.3% |
| 2019 | 20.31 Million TWD | -31.41% |
| 2018 | 29.61 Million TWD | -94.65% |
| 2017 | 553.2 Million TWD | 278.86% |
| 2016 | 146.02 Million TWD | 87.2% |
| 2015 | 78 Million TWD | -25.42% |
| 2014 | 104.59 Million TWD | 49.69% |
| 2013 | 69.87 Million TWD | 72.79% |
| 2012 | 40.44 Million TWD | -82.08% |
| 2011 | 225.73 Million TWD | 1414.37% |
| 2010 | 14.9 Million TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 10.06 Million TWD | 17.13% |
| 2024 Q2 | 121.48 Million TWD | 1107.14% |
| 2023 Q3 | 9.31 Million TWD | -90.64% |
| 2023 FY | 123.13 Million TWD | 239.87% |
| 2023 Q1 | 5.76 Million TWD | 21.95% |
| 2023 Q2 | 99.46 Million TWD | 1626.29% |
| 2023 Q4 | 8.59 Million TWD | -7.72% |
| 2022 Q3 | 19.14 Million TWD | 612.62% |
| 2022 FY | 36.23 Million TWD | -97.2% |
| 2022 Q1 | 9.67 Million TWD | 532.96% |
| 2022 Q2 | 2.68 Million TWD | -72.25% |
| 2022 Q4 | 4.72 Million TWD | -75.31% |
| 2021 Q4 | 1.52 Million TWD | -35.1% |
| 2021 FY | 1.29 Billion TWD | 5426.95% |
| 2021 Q2 | 1.24 Billion TWD | 2596.61% |
| 2021 Q3 | 2.35 Million TWD | -99.81% |
| 2021 Q1 | 46.15 Million TWD | 475.29% |
| 2020 Q3 | 4.58 Million TWD | -38.9% |
| 2020 Q1 | 3.32 Million TWD | -51.28% |
| 2020 Q4 | 8.02 Million TWD | 75.11% |
| 2020 FY | 23.42 Million TWD | 15.3% |
| 2020 Q2 | 7.49 Million TWD | 125.78% |
| 2019 Q3 | 4.79 Million TWD | 15.67% |
| 2019 Q1 | 4.54 Million TWD | -2.92% |
| 2019 Q2 | 4.14 Million TWD | -8.79% |
| 2019 Q4 | 6.81 Million TWD | 42.05% |
| 2019 FY | 20.31 Million TWD | -31.41% |
| 2018 Q1 | 16.78 Million TWD | 539.56% |
| 2018 Q4 | 4.68 Million TWD | -5.41% |
| 2018 Q3 | 4.95 Million TWD | 55.01% |
| 2018 Q2 | 3.19 Million TWD | -80.96% |
| 2018 FY | 29.61 Million TWD | -94.65% |
| 2017 FY | 553.2 Million TWD | 278.86% |
| 2017 Q2 | 530.27 Million TWD | 4257.96% |
| 2017 Q1 | 12.16 Million TWD | -77.93% |
| 2017 Q3 | 8.14 Million TWD | -98.46% |
| 2017 Q4 | 2.62 Million TWD | -67.76% |
| 2016 Q2 | 49.27 Million TWD | 186.77% |
| 2016 Q3 | 24.42 Million TWD | -50.42% |
| 2016 FY | 146.02 Million TWD | 87.2% |
| 2016 Q4 | 55.14 Million TWD | 125.73% |
| 2016 Q1 | 17.18 Million TWD | -10.0% |
| 2015 Q2 | 20.42 Million TWD | 8.68% |
| 2015 Q4 | 19.09 Million TWD | -3.1% |
| 2015 Q3 | 19.7 Million TWD | -3.52% |
| 2015 Q1 | 18.79 Million TWD | -0.94% |
| 2015 FY | 78 Million TWD | -25.42% |
| 2014 Q2 | 18.58 Million TWD | -61.54% |
| 2014 Q1 | 48.32 Million TWD | 164.62% |
| 2014 Q4 | 18.96 Million TWD | 1.32% |
| 2014 FY | 104.59 Million TWD | 49.69% |
| 2014 Q3 | 18.72 Million TWD | 0.72% |
| 2013 Q2 | 17.65 Million TWD | 6.04% |
| 2013 Q4 | 18.26 Million TWD | 5.49% |
| 2013 Q3 | 17.31 Million TWD | -1.93% |
| 2013 FY | 69.87 Million TWD | 72.79% |
| 2013 Q1 | 16.64 Million TWD | -0.67% |
| 2012 Q4 | 16.76 Million TWD | 3.96% |
| 2012 Q3 | 16.12 Million TWD | 0.0% |
| 2012 FY | 40.44 Million TWD | -82.08% |
| 2011 FY | 225.73 Million TWD | 1414.37% |
| 2010 FY | 14.9 Million TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 88.953% |
| Level Biotechnology Inc. | 660.61 Million TWD | 81.361% |
| Sagittarius Life Science Corp | 440.46 Million TWD | 72.044% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | -90.23% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | 45.385% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 68.917% |
| Visgeneer Inc. | 147.99 Million TWD | 16.798% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 92.71% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 32.136% |
| Neith Corporation | 39.9 Million TWD | -208.583% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -441.439% |
| Enimmune corporation | 43.49 Million TWD | -183.106% |
| TaiRx, Inc. | 5.08 Million TWD | -2322.944% |
| EirGenix Inc. | 1.02 Billion TWD | 87.959% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 53.486% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | 71.286% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | -12.034% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | 31.811% |
| Lukas Biomedical Inc. | 231.83 Million TWD | 46.887% |
| RBC Bioscience Corporation | 172.46 Million TWD | 28.604% |
| BiOptic Inc. | 228.26 Million TWD | 46.058% |
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -16814.011% |
| Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -1192.881% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -2438.845% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 93.298% |
| Mycenax Biotech Inc. | 652.62 Million TWD | 81.132% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 68.397% |
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -10093.212% |
| TaiMed Biologics Inc. | 491.77 Million TWD | 74.961% |
| GlycoNex Incorporation | 2.54 Million TWD | -4743.981% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 61.032% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -509.695% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -136715.556% |
| VBI | 55.85 Million TWD | -120.461% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| NaviFUS Corp. | 22.48 Million TWD | -447.725% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 12.78% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -15196.149% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 84.618% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -116.343% |
| AP Biosciences Inc | 32.25 Million TWD | -281.775% |
| Medigen Biotechnology Corp. | 1.15 Billion TWD | 89.364% |
| 3D Global Biotech Inc. | 20.63 Million TWD | -496.782% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 60.848% |
| Intech Biopharm Corporation | 25.84 Million TWD | -376.396% |
| Oneness Biotech Co., Ltd. | 86.78 Million TWD | -41.887% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 83.764% |
| TCI GENE Inc. | 333.85 Million TWD | 63.118% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -683977.778% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -12213.4% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -44.067% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 23.109% |
| PharmaEngine, Inc. | 767.66 Million TWD | 83.96% |
| Savior Lifetec Corporation | 1.05 Billion TWD | 88.276% |
| OBI Pharma, Inc. | 41.54 Million TWD | -196.359% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | 47.455% |
| Acepodia, Inc. | 16.59 Million TWD | -642.084% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -216.28% |